These graphs compare the performance of the biotech stocks for all of 2024 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.

Biopharma money raised to-date and by month in 2023, including public, private and other financings.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Makani Science, Medivis.

New hires and promotions in the med-tech industry, including: Nalu Medical.

Med-tech firms raising money in public or private financings, including: Cytosorbents.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cisbio Bioassays, Medtronic, Methinks, Revvity, Tecan.

BioWorld MedTech briefs for April 4, 2025.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Aldeyra, Cingulate, Meitheal, Mesoblast, Novartis, Resvita Bio, Sanofi, Variant.